European Commission Proposes to Ease Variations Process for Manufacturing Changes
This article was originally published in The Gold Sheet
Executive Summary
CHANGE IS IN THE AIR with the European Commission proposing to simplify and further harmonize the EU variations regulation to ease the global manufacturing change process. The commission would impose a community-wide approach that adds easier “do and tell” procedures for minor variations, includes the ICH design space concept and converges with FDA’s evolving supplement filing process, which will also become easier under a guidance that agency is drafting.
You may also be interested in...
Minor Changes Still Burdensome to Report Under Revised Variations Regulation, European Industry and Competent Authorities Complain
Latest EU variations rewrite leaves both industry and regulators with concerns. Minor changes would still be difficult to implement and pre-notification requirements are seen as unworkable. A plan to subject all biologics changes to prior approval draws ire of biotech sector
Program Participants Urge The FDA To Adopt Some Pharmaceutical Quality Metrics And Avoid Others
Site-based metrics praised; lot acceptance rates, invalidated OOS rates discouraged. Agency official admits some proposed metrics were “not the best.”